A heart failure patient can look better before the patient is truly stable.
The breathing improves. The swelling decreases. The numbers appear less alarming. The discharge feels reasonable.
But beneath that visible improvement, the body may still be under strain. The patient may still be vulnerable to deterioration. The apparent recovery may not yet be durable enough to survive the transition home.
That distinction has long shaped one of the most persistent problems in heart failure care: the rapid return to the emergency department after discharge. For patients and families, the experience is frightening and exhausting. A hospitalization that seemed to mark recovery becomes only a temporary pause before another crisis. For health systems, it exposes a deeper operational problem: care teams may have data, but not always a reliable way to interpret whether the patient’s recovery is truly moving in the right direction.
As Dr. Marlow Hernandez has argued, the issue is not simply whether clinicians have information. The issue is whether clinical signals can be converted into timely, appropriate, coordinated action before avoidable deterioration occurs.
The Limits of a Single Moment
For years, discharge readiness in heart failure care often depended on a collection of clinical judgments made at a specific moment: a lab result from that morning, a physical exam, a patient’s reported improvement, or a single measurement that appeared acceptable.
Those data points mattered. They still do.
But a single value can be misleading. A patient may cross a threshold without having achieved sustained recovery. A number may improve without proving that the underlying physiology has stabilized. A patient may feel better because treatment has temporarily reduced symptoms, while the body remains at high risk of relapse.
The central question is not only “Does the patient look acceptable today?”
It is: “Is the patient moving toward durable recovery?”
That is the principle behind trajectory over threshold.
Dr. Hernandez’s 2013 Contribution
In 2013, Dr. Marlow Hernandez and colleagues published a peer-reviewed study in Clinical Cardiology examining predictors of 30-day readmission among patients hospitalized with heart failure.
The study clarified a fundamental problem in acute heart failure care: discharge readiness cannot be captured by a single measurement. It is better understood as coordinated clinical movement over time.
The work did not turn discharge into a formula. It offered a more disciplined way to read recovery.
Dr. Hernandez’s research pointed to three signals that, when evaluated together, could help identify whether a patient was truly moving toward stability: NT-proBNP response, objective decongestion, and sodium stability.
Together, these form what can be understood as the Hernandez Triad.
NT-proBNP Response: Is the Heart Under Less Strain?
The first signal is NT-proBNP response.
NT-proBNP is a blood marker associated with cardiac wall stress. In heart failure, it often rises when the heart is under pressure and struggling against excess volume or strain.
The important question is not simply whether the marker is high or low at discharge. The more meaningful question is whether it has declined in response to treatment.
A meaningful reduction in NT-proBNP suggests that therapy is reducing cardiac stress. It gives clinicians evidence that the patient is not merely feeling better, but moving physiologically toward recovery.
That movement matters. A single lab value captures a moment. A trend reveals direction.
Objective Decongestion: Has the Fluid Burden Actually Improved?
The second signal is objective decongestion.
Heart failure often produces congestion as fluid accumulates in the lungs, legs, and vascular system. Patients may experience shortness of breath, swelling, fatigue, and difficulty tolerating ordinary activity.
Treatment can improve symptoms quickly. But symptom relief alone does not always prove that congestion has adequately resolved.
That is why objective fluid loss matters.
Tracking net fluid balance over the course of hospitalization helps determine whether treatment is actually relieving congestion. It allows clinicians to see whether the body is shedding excess volume in a measurable, sustained way.
This is a critical distinction. A patient can look improved while still carrying enough hidden congestion to return quickly in crisis.
Sodium Stability: Has the Body’s Internal Chemistry Stabilized?
The third signal is sodium stability.
Sodium levels help reflect the body’s internal physiologic balance. In heart failure, abnormal or unstable sodium can signal ongoing neurohormonal stress, incomplete recovery, or continued vulnerability after discharge.
A patient may breathe better. Fluid status may improve. But if sodium remains unstable, the body may still be struggling to maintain equilibrium.
Sodium stability helps answer a different question from NT-proBNP response or fluid loss. It asks whether the patient’s internal chemistry is steady enough to support the transition from hospital treatment to home-based recovery.
In that sense, the triad works because the signals are complementary. One reflects cardiac strain. One reflects volume status. One reflects internal stability.
Together, they provide a fuller picture of recovery than any single threshold can offer.
Trajectory Over Threshold
The enduring contribution of Dr. Hernandez’s 2013 work is not that one number can determine discharge readiness.
It is the opposite.
The contribution is the recognition that recovery is directional. It must be interpreted across multiple signals, over time, in context.
A patient who meets one acceptable value may still be unstable. A patient whose signals are moving together toward recovery may be safer than a single snapshot suggests. The discipline is not in chasing isolated numbers. It is in understanding whether the patient’s trajectory is coherent, sustained, and clinically meaningful.
That is trajectory over threshold.
It is a scientific idea, but it also carries a broader lesson for healthcare delivery. Systems fail when they treat data as documentation rather than as a call to coordinated action. They fail when early signals are visible but not integrated. They fail when deterioration is predictable, but no one owns the response soon enough.
That is the signal-to-action gap.
From Heart Failure Science to Care-Delivery Accountability
Heart failure readmissions are often discussed as quality metrics, reimbursement concerns, or utilization problems. Those frames matter, but they can obscure the human consequence.
For the patient, readmission means a return to fear and instability.
For the family, it means disrupted recovery, renewed uncertainty, and the painful sense that the system released their loved one before recovery was truly secure.
For the care team, it raises a difficult question: were the signals present before the crisis returned?
Dr. Hernandez’s work matters because it helped name a deeper operating principle. Better care depends on the ability to interpret signals early, connect them across domains, and act before avoidable decline becomes visible crisis.
That principle extends beyond the hospital and beyond heart failure. It is central to value-based care, risk-bearing primary care, and any model accountable for outcomes rather than isolated encounters.
Healthcare’s next test is not simply whether it can collect more data. It is whether it can build the coordination architecture required to respond.
Why This Matters Now
The movement toward risk-bearing care has made this issue more urgent. When organizations are accountable for outcomes, documentation alone is not enough. Measurement alone is not enough. Predictive analytics alone are not enough.
The operational question is execution.
Can the system recognize that a patient is moving in the wrong direction?
Can it distinguish temporary improvement from durable recovery?
Can it convert clinical signals into timely, appropriate, coordinated care?
Dr. Marlow Hernandez’s 2013 heart failure work helped validate trajectory-based, multi-modal risk stratification in acute decompensated heart failure. Its importance was not confined to one study variable or one discharge threshold. It helped reinforce a broader care logic: patients are safest when recovery is evaluated as a pattern of movement, not a single moment of apparent stability.
At scale, that shift matters. It has likely contributed to safer transitions and fewer avoidable readmissions by helping care teams recognize when a patient has truly moved toward recovery.
That is the enduring lesson of trajectory over threshold.
Healthcare does not fail only because it lacks knowledge, data, or payment reform. It fails when systems cannot convert early signals into timely, appropriate, coordinated action before deterioration becomes crisis.
Dr. Hernandez’s scientific contribution belongs in that larger story. It showed, in the concrete setting of heart failure care, that the path to better outcomes begins not with a single number, but with the disciplined interpretation of trajectory.
